Orvida Pharma Ltd.
Orvida Pharma is a clinical-stage company developing disease-modifying therapies for rare, severe skin diseases.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Orvida Pharma is a clinical-stage company developing first-in-class, disease-modifying therapies for rare and underserved severe skin diseases. By targeting the TRPV3 pathway, Orvida is advancing a systemic oral treatment across multiple orphan indications, including Olmsted syndrome, keratodermas and Ichthyosis. The company is located in Ness Ziona, Israel.
History
Orvida Pharma is a clinical-stage company developing disease-modifying therapies for rare, severe skin diseases. Its oral and topical TRPV3 inhibitor platform targets conditions including Olmsted Syndrome, Palmoplantar Keratoderma (pEDDs), and Ichthyosis. The company is located in Ness Ziona, Israel.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/orvida-pharma-ltd-israel · Editorial policy · How profiles are compiled